In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...
My grandfather's (water) pumps... Read More Free Press Journal (FPJ) has been at the forefront of it all, much before India attained her independence. Right from covering the crucial events ...